摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Amino-acetic acid 4-nitro-benzyl ester; compound with trifluoro-acetic acid | 733-71-1

中文名称
——
中文别名
——
英文名称
Amino-acetic acid 4-nitro-benzyl ester; compound with trifluoro-acetic acid
英文别名
(4-Nitrophenyl)methyl 2-aminoacetate;2,2,2-trifluoroacetic acid
Amino-acetic acid 4-nitro-benzyl ester; compound with trifluoro-acetic acid化学式
CAS
733-71-1
化学式
C2HF3O2*C9H10N2O4
mdl
——
分子量
324.213
InChiKey
CIVCOTBMSNNOBU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.23
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    135
  • 氢给体数:
    2
  • 氢受体数:
    10

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and evaluation of a novel 99mTc-labeled bioreductive probe for tumor hypoxia imaging
    摘要:
    Tumor hypoxia is closely associated with the malignant progression and/or the high metastatic ability of tumors and often induces resistance to chemo- and/or radiotherapy. Thus, the detection and evaluation of hypoxia is important for the optimization of cancer therapy. We designed a novel Tc-99m-labeled probe for tumor hypoxia imaging that utilizes bioreductive reactions in hypoxic cells. This probe, which contains a 4-nitrobenzyl ester group, is reduced in hypoxic cells to produce a corresponding carboxylate anion that cannot penetrate cell membranes because of its hydrophilicity and negative charge; therefore, it is expected to be trapped inside hypoxic cells. Based on this unique strategy, we synthesized the Technetium-99m ( Tc-99m)-labeled probe Tc-99m-SD32. The uptake of Tc-99m-SD32 in tumor cells was investigated under normoxic and hypoxic conditions. Tc-99m-SD32 showed sufficient accumulation and good retention in hypoxic cells. In addition, we demonstrated that Tc-99m-SD32 was subjected to bioreduction in hypoxic cells and was trapped as the corresponding carboxylate anion. These results indicated that Tc-99m-SD32 would be a promising agent for in vivo hypoxia imaging. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.10.022
  • 作为产物:
    参考文献:
    名称:
    Synthesis and evaluation of a novel 99mTc-labeled bioreductive probe for tumor hypoxia imaging
    摘要:
    Tumor hypoxia is closely associated with the malignant progression and/or the high metastatic ability of tumors and often induces resistance to chemo- and/or radiotherapy. Thus, the detection and evaluation of hypoxia is important for the optimization of cancer therapy. We designed a novel Tc-99m-labeled probe for tumor hypoxia imaging that utilizes bioreductive reactions in hypoxic cells. This probe, which contains a 4-nitrobenzyl ester group, is reduced in hypoxic cells to produce a corresponding carboxylate anion that cannot penetrate cell membranes because of its hydrophilicity and negative charge; therefore, it is expected to be trapped inside hypoxic cells. Based on this unique strategy, we synthesized the Technetium-99m ( Tc-99m)-labeled probe Tc-99m-SD32. The uptake of Tc-99m-SD32 in tumor cells was investigated under normoxic and hypoxic conditions. Tc-99m-SD32 showed sufficient accumulation and good retention in hypoxic cells. In addition, we demonstrated that Tc-99m-SD32 was subjected to bioreduction in hypoxic cells and was trapped as the corresponding carboxylate anion. These results indicated that Tc-99m-SD32 would be a promising agent for in vivo hypoxia imaging. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.10.022
点击查看最新优质反应信息

文献信息

  • Synthesis of the eicosapeptide corresponding to the N-terminal amino acid sequence of the major component of human lymphoblastoid interferon.
    作者:TAKASHI ABIKO、IKUKO ONODERA、HIROSHI SEKINO
    DOI:10.1248/cpb.29.1390
    日期:——
    An eicosapeptide, H-Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-Asn-Arg-Arg-Ala-Leu-Ile-Leu-Leu-Ala-Gln-OH, corresponding to the N-terminal amino acid sequence of the major component of human lymphoblastoid interferon was synthesized by a conventional method. The final deprotected peptide was purified by gel filtration on Sephadex G-25 and then by partition chromatography on Sephadex G-25. The eicosapeptide at a dose of 100 μg/ml inhibited the incorporation of 3H-thymidine into DNA of PHA-induced lymphocytes by about 15%.
    通过常规方法合成了二十肽 H-Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-Asn-Arg-Arg-Ala-Leu-Ile-Leu-Leu-Ala-Gln-OH,该肽与人淋巴细胞干扰素主要成分的N端氨基酸序列相对应。通过凝胶过滤法(Sephadex G-25)和分区色谱法(Sephadex G-25)对最终去保护肽进行纯化。当剂量达到100微克/毫升时,该二十肽可抑制3H胸苷掺入PHA诱导淋巴细胞DNA的比率约15%。
  • 7-Oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene derivatives
    申请人:HOECHST UK LIMITED
    公开号:EP0174561A1
    公开(公告)日:1986-03-19
    A compound of formula I with R' being an alkyl group substituted by one or more substituents and esters thereof at the 2-carboxy group or at the 8-hydroxy group or both: and salts thereof. Compounds I have antibacterial effect. Various intermediates are described. This compound of the formula I, or an ester at the 2-carboxy group or at the 8-hydroxy group or both or a salt thereof is produced by reacting a compound of formula II or of formula IX in which R represents a hydrogen atom or a carboxy protecting group, R3 represents an activated carboxylic acid group, R4 represents an alkyl group having 1 to 4 carbon atoms, or a phenyl group which may be unsubstituteo or substituted, R15 represents a phenyl group or an alkyl group having from 1 to 4 carbon atoms, and X represents an oxygen c, sulphur with an amine of the formula III R'NH2 (III), to give a compound of formula I, or an ester therecf of formula la
    式 I 的化合物 R'为被一个或多个取代基取代的烷基及其 2-羧基或 8-羟基或两者的酯类:及其盐类。化合物 I 具有抗菌作用。描述了各种中间体。将式 II 或式 IX 的化合物与 2-羧基或 8-羟基或两者的或其盐反应,可制得式 I 化合物。 其中 R 代表原子或羧基保护基团,R3 代表活化的羧酸基团,R4 代表具有 1 至 4 个原子的烷基或基(可以是未取代的基或取代的基),R15 代表基或具有 1 至 4 个原子的烷基,X 代表 c、与式 III R'NH2 (III) 的胺反应,得到式 I 的化合物或式 la 的
  • US4849419A
    申请人:——
    公开号:US4849419A
    公开(公告)日:1989-07-18
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸